. Author manuscript; available in PMC: 2018 Apr 28.

Published in final edited form as: Br J Haematol. 2016 Feb 23;173(2):283–291. doi: 10.1111/bjh.13957

Table 2.

Response rates to BR induction therapy.

Enrolled population (n=34)^†
Response	n (%)	95% CI
CR	7 (21)	9-38%
PR	12 (35)	20-54%
SD	9 (26)	13-44%
ORR	19 (56)	38-73%
Subgroup with known 11q or 17p deletions (n=11)
Response	n (%)	95% CI
CR	1 (9)	0-41%
PR	5 (45)	17-77%
SD	4 (36)	11-69%
ORR	6 (55)	23-83%

CI=confidence interval, CR=complete response, ORR=overall response rate, PR=partial response, SD=stable disease

^†

3 patients were not evaluable for response, but included in the intent-to-treat analysis.